R1	Has_qualifier Arg1:T3 Arg2:T4	
R2	Has_value Arg1:T5 Arg2:T6	
R3	AND Arg1:T3 Arg2:T5	
R4	Has_qualifier Arg1:T7 Arg2:T8	
*	OR T12 T13 T14
R5	Subsumes Arg1:T7 Arg2:T9	
R6	Has_qualifier Arg1:T16 Arg2:T17	
R7	Has_value Arg1:T18 Arg2:T19	
R8	Has_value Arg1:T21 Arg2:T22	
R9	AND Arg1:T20 Arg2:T21	
R10	AND Arg1:T16 Arg2:T18	
*	OR T16 T20
*	OR T23 T24 T25
R11	Subsumes Arg1:T25 Arg2:T26	
R12	Has_qualifier Arg1:T27 Arg2:T23	
*	OR T31 T30
R13	Has_qualifier Arg1:T29 Arg2:T31	
*	OR T33 T34 T35 T36 T37 T38 T39
R14	Subsumes Arg1:T29 Arg2:T33	
R15	Has_value Arg1:T41 Arg2:T42	
*	OR T44 T43
R16	Has_temporal Arg1:T47 Arg2:T48	
*	OR T52 T53
R17	AND Arg1:T51 Arg2:T52	
R18	AND Arg1:T49 Arg2:T50	
R19	Subsumes Arg1:T49 Arg2:T51	
R20	Has_qualifier Arg1:T58 Arg2:T57	
*	OR T71 T72
R21	Has_negation Arg1:T71 Arg2:T70	
*	OR T67 T69 T68
R22	Subsumes Arg1:T66 Arg2:T67	
R23	Has_negation Arg1:T64 Arg2:T63	
R24	Has_temporal Arg1:T62 Arg2:T65	
R25	Has_qualifier Arg1:T60 Arg2:T59	
R26	Has_temporal Arg1:T60 Arg2:T61	
*	OR T60 T62 T66
R27	Subsumes Arg1:T58 Arg2:T60	
R28	Has_qualifier Arg1:T78 Arg2:T79	
R29	Has_temporal Arg1:T78 Arg2:T80	
R30	Has_index Arg1:T80 Arg2:T81	
*	OR T83 T84 T85
R31	Has_multiplier Arg1:T83 Arg2:T87	
R32	Has_qualifier Arg1:T82 Arg2:T83	
R33	Has_temporal Arg1:T82 Arg2:T86	
R34	Subsumes Arg1:T7 Arg2:T10	
R35	Subsumes Arg1:T7 Arg2:T11	
R36	Subsumes Arg1:T7 Arg2:T12	
R37	Has_temporal Arg1:T64 Arg2:T65	
T1	Competing_trial 0 80	Treatment with any investigational drug within 30 days of entry to this protocol
T2	Drug 105 116	Telbivudine
T3	Condition 125 134	hepatitis
T4	Qualifier 118 124	Severe
T5	Measurement 161 164	ALT
T6	Value 164 173	>10 x ULN
T7	Condition 200 209	cirrhosis
T8	Qualifier 186 199	decompensated
T9	Condition 222 230	jaundice
T10	Condition 250 259	cirrhosis
T11	Condition 261 268	ascites
T12	Condition 270 286	bleeding gastric
T13	Condition 290 308	esophageal varices
T14	Condition 312 326	encephalopathy
T16	Condition 342 353	neutropenia
T17	Qualifier 329 341	Pre-existent
T18	Measurement 355 366	neutrophils
T19	Value 367 377	<1,500/mm3
T20	Condition 382 398	thrombocytopenia
T21	Measurement 400 409	platelets
T22	Value 410 422	< 90,000/mm3
T23	Qualifier 443 460	hepatitis C virus
T24	Qualifier 462 479	hepatitis D virus
T25	Qualifier 483 511	human immunodeficiency virus
T26	Qualifier 513 516	HIV
T27	Condition 425 437	Co-infection
T29	Condition 557 570	liver disease
T30	Qualifier 537 546	inherited
T31	Qualifier 525 533	acquired
T33	Condition 572 595	alcoholic liver disease
T34	Condition 597 626	obesity induced liver disease
T35	Condition 628 654	drug related liver disease
T36	Condition 656 677	auto-immune hepatitis
T37	Condition 679 694	hemochromatosis
T38	Condition 696 712	Wilson's disease
T39	Condition 716 746	alpha-1 antitrypsin deficiency
T41	Measurement 748 765	Alpha fetoprotein
T42	Value 766 776	> 50 ng/ml
T43	Condition 788 802	hypothyroidism
T44	Condition 778 783;792 802	Hyper thyroidism
T45	Drug 823 833	medication
T46	Non-query-able 804 939	subjects requiring medication to maintain TSH levels in the normal range are eligible if all other inclusion/exclusion criteria are met
T47	Procedure 942 970	Immune suppressive treatment
T48	Temporal 971 999	within the previous 6 months
T49	Condition 1001 1019	Contra-indications
T50	Drug 1024 1047	alfa-interferon therapy
T51	Condition 1063 1079	hypersensitivity
T52	Drug 1083 1093	interferon
T53	Drug 1097 1110	Peginterferon
T54	Non-query-able 1114 1239	any known pre-existing medical condition that could interfere with the patient's participation in and completion of the study
T56	Pregnancy_considerations 1242 1267	Pregnancy, breast-feeding
T57	Qualifier 1275 1286	significant
T58	Condition 1287 1302	medical illness
T59	Qualifier 1341 1352	significant
T60	Condition 1353 1374	pulmonary dysfunction
T61	Temporal 1375 1399	in the previous 6 months
T62	Condition 1401 1411	malignancy
T63	Negation 1412 1422	other than
T64	Condition 1423 1450	skin basocellular carcinoma
T65	Temporal 1451 1470	in previous 5 years
T66	Condition 1472 1498	immunodeficiency syndromes
T67	Condition 1505 1519	HIV positivity
T68	Condition 1521 1541	auto-immune diseases
T69	Procedure 1543 1560	organ transplants
T70	Negation 1561 1571	other than
T71	Procedure 1572 1578;1588 1598	cornea transplant
T72	Procedure 1583 1598	hair transplant
T78	Drug 1663 1671;1690 1698	systemic steroids
T79	Qualifier 1655 1662	chronic
T80	Temporal 1700 1730	during the course of the study
T81	Reference_point 1711 1730	course of the study
T82	Condition 1732 1747	Substance abuse
T83	Qualifier 1757 1764	alcohol
T84	Qualifier 1778 1788	I.V. drugs
T85	Qualifier 1793 1806	inhaled drugs
T86	Temporal 1807 1827	in the past 2 years.
T87	Multiplier 1766 1775	>80 g/day
T89	Non-query-able 1829 2017	Any other condition which in the opinion of the investigator would make the patient unsuitable for enrollment, or could interfere with the patient participating in and completing the study
